Trial intelligence / Profile preview

Botulinum toxin type B for plantar hyperhidrosis

2009-011042-26Phase 2Completed

Sponsor
Medical University of Vienna
Start
Aug 2011
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 2, randomised trial of botulinum toxin type b in plantar hyperhidrosis, sponsored by Medical University of Vienna. Primary endpoint: Primary: sweat reduction. Started Aug 2011; status: completed.

02

Drugs

botulinum toxin type b
03

Conditions

plantar hyperhidrosis

Beyond the preview

Go deeper on 2009-011042-26.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2009-011042-26.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call